Selin Somersan-Karakaya is an Infectious Disease physician affiliated with Regeneron. OpenAlex indexes 38 publications with 946 citations (h-index 15).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingNIH funding
1 NIH research award on record, funded 2014–2018 per NIH RePORTER. The latest:
- Calanolides as tools to find new drug targets for Mycobacterium tuberculosis
Weill Medical Coll of Cornell Univ
FY2018$193,320K08AI108799 - Calanolides as tools to find new drug targets for Mycobacterium tuberculosis
Weill Medical Coll of Cornell Univ
FY2017$193,320K08AI108799 - Calanolides as tools to find new drug targets for Mycobacterium tuberculosis
Weill Medical Coll of Cornell Univ
FY2016$180,652K08AI108799
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Ofri Mosenzon
Regeneron
Nikhil Amin, MD
Regeneron
Robert Vitti, MD
Regeneron
Thomas Uldrick, MD
Regeneron
Thomas Walsh, MD
Cornell University
Vance Fowler, MD
Duke University
Myron Cohen, MD
University of North Carolina at Chapel Hill School of Medicine
Derrick W. Crook
John Radcliffe Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”